期刊文献+

阿托伐他汀对人NK细胞杀伤HCT-116细胞的影响及其机制研究 被引量:2

The effect and mechanism of Atorvastatin on the cytotoxicity of human NK cells to HCT-116 cells
下载PDF
导出
摘要 目的探讨阿托伐他汀对人自然杀伤细胞(natural killer,NK)杀伤HCT-116细胞的影响及其机制。方法 CCK-8法测定不同浓度的阿托伐他汀对HCT-116细胞生长抑制率的影响。自动生化分析仪测NK细胞对HCT-116细胞的杀伤活性;流式细胞仪(FCM)检测HCT-116细胞MICA/B的表达率。结果不同浓度的阿托伐他汀作用于HCT-116细胞48 h后在浓度为5~40μmol/L及作用96 h后在浓度为1.25~40μmol/L时,对HCT-116细胞的生长抑制率与对照组相比差异有统计学意义(P〈0.05)。阿托伐他汀浓度相同时,HCT-116细胞的生长抑制率在48 h组与96 h组相比,除5μmol/L浓度组外差异均有统计学意义(P〈0.05)。阿托伐他汀的浓度与HCT-116细胞的生长抑制率呈正相关(r[48 h]=0.13,r[96 h]=0.22,P〈0.05)。NK细胞对HCT-116细胞的杀伤活性在阿托伐他汀浓度为2.5~10μmol/L各组中均显著高于对照组(P〈0.05)。2.5μmol/L浓度组及5μmol/L浓度组,HCT-116细胞MICA/B的表达率与对照组比较显著升高(P〈0.05)。结论阿托伐他汀呈剂量依赖性抑制HCT-116细胞的生长,且延长作用时间可以增强阿托伐他汀对HCT-116细胞生长的抑制作用;还能够增强NK细胞对HCT-116杀伤活性;以及上调HCT-116细胞MICA/B的表达率,提高其免疫原性。 Objective To investigate the mechanism of the cytotoxicity of NK cell induced by Atorvastatin to HCT-116 cells. Methods The effect of different concentrations of Atorvastatin on the growth of HCT-116 cells was measured by CCK-8. Automatic biochemical analyzer was applied to test the cytotoxicity of NK cells to HCT-116 cells. Flow cytometry( FCM) was used to detect the expression rate of MICA / B in the cells. Results Atorvastatin could inhibit the growth of HCT-116 cells,the inhitbition rates of HCT-116 were higher than those in the control group in different concentrations of Atorvastatin treatment 48 hours and 96 hours. Statistical analysis showed that the inhibition rates of HCT-116 had significant difference compared with the control group( P〈0. 05) when Atorvastatin was 5-40 μmol / L after48 hours and 1. 25-40 μmol / L after 96 hours. Correlation analysis showed that the concentration of Atorvastatin and the growth inhibition rate of HCT-116 cells were positively correlated( r[48 h]= 0. 13,r[96 h]= 0. 22,P〈0. 05). The cytotoxicity of NK cells to HCT-116 cells was higher than the control group when Atorvastatin was 2. 5-10 μmol / L( P〈0. 05). The expression of MICA / B on HCT-116 cells was higher than the control group( P〈0. 05) in the concentration of 2. 5 μmol / L and 5 μmol / L. Conclusion Atorvastatin could inhibit the growth of HCT-116 cells in a dose-dependent manner; and it could enhance the cytotoxic activity of the NK cells to HCT-116 cells; it also could promote the expression of MICA / B on HCT-116 cells,and improve the immunogenicity of HCT-116 cells.
出处 《胃肠病学和肝病学杂志》 CAS 2016年第3期304-307,共4页 Chinese Journal of Gastroenterology and Hepatology
基金 南京军区医学科技创新课题(13MA039)
关键词 阿托伐他汀 HCT-116细胞 自然杀伤细胞 MICA/B Atorvastatin HCT-116 Natural Killer cells MICA/B
  • 相关文献

参考文献15

  • 1Shaukat A, Mongin SJ, Geisser MS, et al. Long-term mortality after screening for colorectal cancer [ J]. N Engl J Med, 2013, 369 (12) : 1106-1114.
  • 2Siegel R, Naishadham D, Jemal A. Cancer stalistics 2012 [J]. CA Cancer J Clin, 2012, 62(1) : 10-29.
  • 3赵心彬,倪敏,陶霞.他汀类药物多效药理作用及其机制研究进展[J].药学实践杂志,2013,31(1):19-21. 被引量:22
  • 4陈万青,郑荣寿,曾红梅,邹小农,张思维,赫捷.2011年中国恶性肿瘤发病和死亡分析[J].中国肿瘤,2015,24(1):1-10. 被引量:864
  • 5Zhang X, Jin J, Peng X, et al. Simvastatin inhibits IL-17 secretion by inhibiting the expression of IL-17 transcription factor RORC in CD4^+ lymphocytes [J]. J Immunol, 2008, 180( 10):6988-6996.
  • 6苏克莉,尹林林,李静.他汀类药物抗肿瘤作用机制[J].国际肿瘤学杂志,2013,40(5):342-344. 被引量:5
  • 7Park IH, Kim JY, Jung JI, et al. Lovastatin overcomes gefitinib resistance in human non-small cell lung canecr cells with K-Ras mutations [J]. Invest New Drugs, 2010, 28(6) : 791-799.
  • 8Cho SJ, Kim JS, Kim JM, et al. Simvastafin induces apoptasis in human colon cancer cells and in tumor xenografts and attenuates colitisassociated colon cancer in mice [J]. Int J Cancer, 2008, 123 (4) : 951-957.
  • 9Zwirner NW, Fuertes MB, Girart MV, et al. Cytokine-driven regulation of NK cell functions in tumor immunity:role of the MICA-NKG2D system [J]. Cytokine Growth Factor Rev, 2007, 18( 1-2): 159-170.
  • 10Pende D, Rivera P, Marcenaro S, et al. Major histocompatibility complex class I-related chain A and UL16-binding protein expression on tumor cell lines of different histotypes : analysis of tumor susceptibility to NKG2D-dependent natural killer cell cytotoxicity [ J]. Cancer Res, 2002, 62(21): 6178-6186.

二级参考文献61

  • 1陈巧玲,蔡宝祥.他汀类药物防治动脉粥样硬化作用研究进展[J].药学实践杂志,2006,24(6):321-324. 被引量:4
  • 2吴苏舒,刘玉明,陈静.他汀类药物调脂外临床应用概况[J].药学实践杂志,2007,25(1):4-6. 被引量:8
  • 3全国肿瘤登记中心.中国肿瘤登记工作指导手册[M].北京:中国协和医科大学出版社,2004.48-50.
  • 4Bardou M, Barkun A, Marte! M. Effect of statin therapy on colorectal cancer. Gut, 2010, 59(11) :1572-1585.
  • 5Park IH, Kim JY, Jung JI. Lovastatin overcomes gefitinib resistance in human non-small cell lung cancer cells with K-Ras mutations. Invest New Drugs, 2010, 28 (6) :791-799.
  • 6OgunWe bimerola ,pptsis2008in ,OOB'arrett'l SO3 (4) :825-837B.ealesphageI alL" Statinaencarcinin mahibit prliferatic nells" AmandJ ce.
  • 7Cho SJ, Kim JS, Kim JM, et al. Simvastatin induces apoptosis in human colon cancer cells and in tumor xenografts, and attenuates colitis-asso- ciated colon cancer in mice. Int J Cancer, 2008, 123(4) :951-957.
  • 8Yacoub A, Hawkins W, Hanna D, et al. Human chofionic gonadotro- pin modulates prostate cancer cell survival after irradiation or HMG CoA reductase inhibitor treatment. Mol Pharmacol, 2007, 71 ( 1 ) : 259 -275.
  • 9Minichsdorfer C, Hohenegger M. Autocrine amplification loop in sta- tin-induced apoptosis of human melanoma cells. Br J Pharmacol, 2009, 157(7) :1278-1290.
  • 10Vosler PS, Sun D, Wang S, et al. Calcium dysregulation induces ap-optosis-inducing factor release: cress-talk between PARP-1- and cal- pain-signaling pathways. Exp Neurol, 2009, 218 ( 2 ) : 213 -220.

共引文献886

同被引文献16

引证文献2

二级引证文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部